查看購物車
  • English
  • Japanese
歐洲生物資訊市場：按產品和服務、產業、應用和國家分類的分析和預測（2025-2035 年）
市場調查報告書
商品編碼
1915216

歐洲生物資訊市場：按產品和服務、產業、應用和國家分類的分析和預測（2025-2035 年）

Europe Bioinformatics Market: Focus on Product and Services, Sector, Application, and Country - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 68 Pages | 商品交期: 1-5個工作天內

價格

歐洲生物資訊市場規模預計將從2024年的42.7億美元成長到2035年的154.2億美元，在預測期（2025-2035年）內年複合成長率為 12.42%。

生物資訊學是融合學科，結合了電腦科學、生物學、化學、數學和統計學，用於評估複雜的生物資料。它對於理解生物分子和系統的組成、功能和發育非常重要，並支持蛋白質相互作用的研究、疾病相關基因的鑑定以及基因表現分析。此外，它在代謝通路研究、精準醫療和藥物研發中也發揮關鍵作用。次世代定序技術加速基因組資料的成長，增加了醫療保健和研究領域對生物資訊工具的需求。人工智慧和機器學習的發展進一步提升了資料分析能力，鞏固了生物資訊學在歐洲醫療保健、遺傳學和生命科學研究領域的關鍵地位。

關鍵市場統計資料
預測期 2025-2035
2025年評估 47.8億美元
2035年預測 154.2億美元
年複合成長率 12.42%

市場概覽

受系統生物學、蛋白質組學和基因組學領域對高級資料分析需求的日益成長的推動，歐洲生物資訊市場正經歷顯著成長。生物資訊整合了生物學、化學、數學、統計學和電腦技術，用於管理和解讀複雜的生物資料集，使研究人員和醫學專業人員能夠了解分子結構、基因活性和蛋白質相互作用。其應用領域包括個人化醫療、藥物研發、疾病相關基因的鑑定以及代謝和訊號網路的分析。

次世代定序（NGS）、高通量篩檢和分子診斷技術的進步推動了基因組資料的快速成長，進而促進了市場發展。精準醫療計畫在歐洲各國的日益普及，使得標靶治療成為可能，並改善了患者的治療效果，推動了對生物資訊解決方案的需求。研究機構、製藥公司和生技公司正積極投資生物資訊平台，以提高效率、加速藥物研發並實現資料驅動的決策。

雲端運算、人工智慧和機器學習等技術進步正使生物資訊分析更快、更準確、更具可擴展性。政府目的是促進基因組學研究、支持生命科學創新以及加強歐洲合作的計畫也為市場提供了支持。儘管面臨資料安全和合格專業人員短缺等挑戰，生物資訊學仍然是歐洲醫療保健、基因組學和生命科學研究領域的重要組成部分，並具有進一步技術發展和進步的空間。

市場區隔:

細分 1：依產品/服務

  • 生物資訊軟體和工具
  • 生物資訊服務

細分 2：依行業

  • 醫學生物技術
  • 動物生物技術
  • 植物生物技術
  • 法醫學生物技術
  • 其他

細分 3：依應用

  • 基因組學
  • 蛋白質體學
  • 轉錄組學
  • 代謝體學
  • 其他

細分 4：依地區

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他

本報告調查歐洲生物資訊市場，並總結了關鍵趨勢、市場影響因素分析、法律制度、市場規模趨勢和預測、按各個細分市場、地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。

目錄

執行摘要

範圍和定義

第1章 歐洲生物資訊學市場：產業展望

  • 市場趨勢：當前及未來影響評估
    • 人工智慧和機器學習在生物資訊解決方案中的策略整合
    • 將多體學資料整合到生物資訊市場
    • 量子計算變革生物資訊學
  • 監管狀態
  • 定價分析
  • 市場動態
    • 市場促進因素
    • 市場挑戰
    • 市場機會

第2章 各地區生物資訊市場

  • 歐洲
    • 區域概覽
    • 市場成長促進因素
    • 市場問題
    • 分析師觀點
    • 市場規模及預測

第3章 競爭標竿分析與公司概況

  • 公司簡介
    • Eurofins Scientific
    • Fios Genomics
    • QIAGEN
    • SOPHiA GENETICS

第4章 調查方法

Product Code: BHD3547SS

This report can be delivered in 2 working days.

Introduction to Europe Bioinformatics Market

The Europe bioinformatics market is projected to reach $15.42 billion by 2035 from $4.27 billion in 2024, growing at a CAGR of 12.42% during the forecast period 2025-2035. In Europe, bioinformatics is an interdisciplinary field that combines computer science, biology, chemistry, mathematics, and statistics to evaluate complicated biological data. It is essential for comprehending the composition, operation, and development of biomolecules and systems, supporting research on protein interactions, disease gene identification, and gene expression analysis. Additionally, the field is essential for metabolic pathway research, precision medicine, and drug development. Next-generation sequencing technologies have accelerated the growth of genomic data, which has raised demand for bioinformatics tools in the healthcare and research sectors. AI and machine learning developments are improving data analysis even further, solidifying bioinformatics as a key component of European healthcare, genetics, and life sciences research.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$4.78 Billion
2035 Forecast$15.42 Billion
CAGR12.42%

Market Introduction

The market for bioinformatics in Europe is expanding significantly due to the growing need for sophisticated data analysis in systems biology, proteomics, and genomics. Researchers and medical professionals can comprehend molecular structures, gene activities, and protein interactions by using bioinformatics, which combines biology, chemistry, mathematics, statistics, and computer technology to manage and interpret complex biological datasets. Personalized medicine, drug discovery, illness gene identification, and the investigation of metabolic and signaling networks are some of its uses.

The market growth is propelled by the rapid expansion of genomic data, supported by developments in next-generation sequencing (NGS) technologies, high-throughput screening, and molecular diagnostics. The demand for bioinformatics solutions has increased due to the growing adoption of precision medicine programs throughout European nations, which allow for focused therapies and better patient outcomes. In order to improve productivity, shorten the time it takes to discover new drugs, and enable data-driven decision-making, research institutes, pharmaceutical corporations, and biotechnology companies are actively investing in bioinformatics platforms.

Bioinformatics analyses are becoming faster, more accurate, and more scalable thanks to technological advancements like cloud computing, artificial intelligence, and machine learning. The market is also being supported by government programs that encourage genomics research, innovation in the life sciences, and cooperative ventures around Europe. Bioinformatics is still a vital part of Europe's healthcare, genomics, and life sciences research environment, with room to develop and advance technologically despite obstacles such data security issues and the need for qualified experts.

Market Segmentation:

Segmentation 1: By Product and Services

  • Bioinformatics Software and Tools
  • Bioinformatics Services

Segmentation 2: By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Forensic Biotechnology
  • Others

Segmentation 3: By Application

  • Genomics
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Others

Segmentation 4: By Region

  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest-of-Europe

Europe Bioinformatics Market Trends, Drivers and Challenges

Market Trends

  • Increasing integration of AI and machine learning for faster, more accurate data analysis
  • Growing use of cloud-based bioinformatics platforms for scalable data storage and collaboration
  • Rising adoption of next-generation sequencing (NGS) and high-throughput technologies in genomics and proteomics research
  • Expansion of precision medicine and personalized therapy programs across hospitals and research centers
  • Enhanced application of bioinformatics in drug discovery, molecular diagnostics, and biomarker identification
  • Growing collaborations between pharmaceutical companies, academic institutions, and technology providers to advance bioinformatics research

Market Drivers

  • Rapid increase in genomic, proteomic, and metabolomic data requiring sophisticated analysis tools
  • Rising demand for personalized medicine and targeted therapeutics in Europe
  • Strong government and EU initiatives promoting life sciences research and genomics projects
  • Expansion of biotechnology and pharmaceutical R&D activities in key European countries
  • Technological advancements in AI, machine learning, and data analytics improving bioinformatics capabilities
  • Need to reduce drug development timelines and enhance research efficiency

Market Challenges

  • Shortage of skilled bioinformatics professionals to manage and interpret complex datasets
  • High costs associated with advanced bioinformatics platforms and software
  • Data privacy and security concerns, particularly with patient genomic information
  • Integration challenges across diverse datasets and legacy systems
  • Regulatory compliance complexities for clinical and healthcare bioinformatics applications

How can this report add value to an organization?

Product/Innovation Strategy: The Europe bioinformatics market has been extensively segmented based on various categories, such as product and services, sector, application, and region. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Europe bioinformatics market has numerous established players with product portfolios. Key players in the Europe bioinformatics market, analyzed and profiled in the study, include established players offering products and services for bioinformatics.

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Eurofins Scientific
  • Fios Genomics Ltd.
  • QIAGEN
  • SOPHiA GENETICS

Table of Contents

Executive Summary

Scope and Definition

1 Europe Bioinformatics Market: Industry Outlook

  • 1.1 Market Trends: Current and Future Impact Assessment
    • 1.1.1 Strategic Integration of AI and ML in Bioinformatics Solutions
    • 1.1.2 Integration of Multi-Omics Data in the Bioinformatics Market
    • 1.1.3 Quantum Computing to Transform Bioinformatics
  • 1.2 Regulatory Landscape
  • 1.3 Pricing Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Market Drivers
      • 1.4.1.1 Rising Private and Public Investments in the Bioinformatics Industry
      • 1.4.1.2 Growing Demand for Bioinformatics in Drug Discovery
      • 1.4.1.3 Expanding Genomic Data Propelling the Demand for Bioinformatics Tools
    • 1.4.2 Market Challenges
      • 1.4.2.1 Data Complexity and Heterogeneity Limiting Bioinformatics Growth
      • 1.4.2.2 Ethical and Data Privacy Challenges Impacting Bioinformatics Adoption
    • 1.4.3 Market Opportunities
      • 1.4.3.1 Rising Importance of Metagenomics Offering Growth Potential for Bioinformatics

2 Bioinformatics Market, by Region, $Billion, 2023-2035

  • 2.1 Europe
    • 2.1.1 Regional Overview
    • 2.1.2 Driving Factors for Market Growth
    • 2.1.3 Factors Challenging the Market
    • 2.1.4 Analyst View
    • 2.1.5 Market Sizing and Forecast
      • 2.1.5.1 Europe Bioinformatics Market (by Product and Services)
      • 2.1.5.2 Europe Bioinformatics Market (by Application)
      • 2.1.5.3 Europe Bioinformatics Market (by Sector)
      • 2.1.5.4 Europe Bioinformatics Market (by Country)
        • 2.1.5.4.1 U.K.
          • 2.1.5.4.1.1 Country Overview
          • 2.1.5.4.1.2 Driving Factors Market Growth
          • 2.1.5.4.1.3 Factors Challenging the Market
          • 2.1.5.4.1.4 Analyst View
          • 2.1.5.4.1.5 Market Sizing and Forecast
        • 2.1.5.4.2 Germany
          • 2.1.5.4.2.1 Country Overview
          • 2.1.5.4.2.2 Driving Factors Market Growth
          • 2.1.5.4.2.3 Factors Challenging the Market
          • 2.1.5.4.2.4 Analyst View
          • 2.1.5.4.2.5 Market Sizing and Forecast
        • 2.1.5.4.3 France
          • 2.1.5.4.3.1 Country Overview
          • 2.1.5.4.3.2 Driving Factors Market Growth
          • 2.1.5.4.3.3 Factors Challenging the Market
          • 2.1.5.4.3.4 Analyst View
          • 2.1.5.4.3.5 Market Sizing and Forecast
        • 2.1.5.4.4 Italy
          • 2.1.5.4.4.1 Country Overview
          • 2.1.5.4.4.2 Driving Factors Market Growth
          • 2.1.5.4.4.3 Factors Challenging the Market
          • 2.1.5.4.4.4 Analyst View
          • 2.1.5.4.4.5 Market Sizing and Forecast
        • 2.1.5.4.5 Spain
          • 2.1.5.4.5.1 Country Overview
          • 2.1.5.4.5.2 Driving Factors Market Growth
          • 2.1.5.4.5.3 Factors Challenging the Market
          • 2.1.5.4.5.4 Analyst View
          • 2.1.5.4.5.5 Market Sizing and Forecast
        • 2.1.5.4.6 Rest-of-Europe
          • 2.1.5.4.6.1 Regional Overview
          • 2.1.5.4.6.2 Driving Factors Market Growth
          • 2.1.5.4.6.3 Factors Challenging the Market
          • 2.1.5.4.6.4 Analyst View
          • 2.1.5.4.6.5 Market Sizing and Forecast

3 Competitive Benchmarking and Company Profiles

  • 3.1 Company Profiles
    • 3.1.1 Eurofins Scientific
      • 3.1.1.1 Overview
      • 3.1.1.2 Top Products/Product Portfolio
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Target Customers
      • 3.1.1.5 Key Personnel
      • 3.1.1.6 Analyst View
    • 3.1.2 Fios Genomics
      • 3.1.2.1 Overview
      • 3.1.2.2 Top Products/Product Portfolio
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Target Customers
      • 3.1.2.5 Key Personnel
      • 3.1.2.6 Analyst View
    • 3.1.3 QIAGEN
      • 3.1.3.1 Overview
      • 3.1.3.2 Top Products/Product Portfolio
      • 3.1.3.3 Top Competitors
      • 3.1.3.4 Target Customers
      • 3.1.3.5 Key Personnel
      • 3.1.3.6 Analyst View
    • 3.1.4 SOPHiA GENETICS
      • 3.1.4.1 Overview
      • 3.1.4.2 Top Products/Product Portfolio
      • 3.1.4.3 Top Competitors
      • 3.1.4.4 Target Customers
      • 3.1.4.5 Key Personnel
      • 3.1.4.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Bioinformatics Market (by Scenario), $Billion, 2024, 2025, and 2035
  • Figure 2: Europe Bioinformatics Market (by Product and Services), $Billion, 2024, 2029, and 2035
  • Figure 3: Europe Bioinformatics Market (by Sector), $Billion, 2024, 2029, and 2035
  • Figure 4: Europe Bioinformatics Market (by Application), $Billion, 2024, 2029, and 2035
  • Figure 5: Bioinformatics Market, $Billion, 2024 and 2035
  • Figure 6: Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 7: U.K. Bioinformatics Market, $Billion, 2023-2035
  • Figure 8: Germany Bioinformatics Market, $Billion, 2023-2035
  • Figure 9: France Bioinformatics Market, $Billion, 2023-2035
  • Figure 10: Italy Bioinformatics Market, $Billion, 2023-2035
  • Figure 11: Spain Bioinformatics Market, $Billion, 2023-2035
  • Figure 12: Rest-of-Europe Bioinformatics Market, $Billion, 2023-2035
  • Figure 13: Data Triangulation
  • Figure 14: Top-Down and Bottom-Up Approach
  • Figure 15: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Key Market Trends
  • Table 3: Bioinformatics Market, Regulatory Landscape
  • Table 4: Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
  • Table 5: Some of the Public and Private Funding in the Bioinformatics Industry
  • Table 6: Bioinformatics Market (by Region), $Billion, 2023-2035
  • Table 7: Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 8: Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 9: Europe Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 10: Europe Bioinformatics Market (by Country), $Billion, 2023-2035
  • Table 11: U.K. Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 12: U.K. Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 13: U.K. Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 14: Germany Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 15: Germany Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 16: Germany Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 17: France Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 18: France Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 19: France Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 20: Italy Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 21: Italy Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 22: Italy Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 23: Spain Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 24: Spain Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 25: Spain Bioinformatics Market (by Sector), $Billion, 2023-2035
  • Table 26: Rest-of-Europe Bioinformatics Market (by Product and Services), $Billion, 2023-2035
  • Table 27: Rest-of-Europe Bioinformatics Market (by Application), $Billion, 2023-2035
  • Table 28: Rest-of-Europe Bioinformatics Market (by Sector), $Billion, 2024-3-2035